- Direct Oral Anticoagulant Thromboprophylaxis Trials for Ambulatory Cancer Patients: Guideline Changing, but Are They Practice Changing?January 02, 2020 | January-February 2020, Volume 17, Issue 1
Dr. Linkins discusses direct oral anticoagulant thromboprophylaxis trials that compare risks and benefits for patients who are hospitalized or undergoing surgery.
- Pressing PAUSE on Direct Oral Anticoagulants for Patients With Atrial Fibrillation Who Require Invasive ProceduresOctober 17, 2019 | November-December 2019, Volume 16, Issue 6
Dr. Linkins discusses a study that evaluated the safety of a standardized perioperative management strategy for patients with atrial fibrillation taking direct oral anticoagulants who required elective surgery or procedure.
- Diagnostic Algorithm Reduces the Need for Radiation Exposure to Rule Out Pulmonary Embolism in Pregnant WomenAugust 22, 2019 | September-October 2019, Volume 16, Issue 5
Dr. Linkins looks at using algorithms based on clinical prediction rules and blood testing for D-dimer level to diagnose pulmonary embolism (PE), thus reducing the need for CTPA in patients with suspected PE.
- Superficial Thrombophlebitis: The Less Dangerous Cousin of Deep Vein Thrombosis That Can Still Cause HarmMay 22, 2019 | July-August 2019, Volume 16, Issue 4
Dr. Linkins provides recommendations for treating superficial thrombophlebitis including whether anticoagulants are appropriate based on the risk of progression into the deep venous system.
- Thrombolysis for Acute Pulmonary Embolism Is Not One-Size-Fits-AllApril 10, 2019 | May-June 2019, Volume 16, Issue 3
Dr. Linkins discusses the use of thrombolysis for treatment of pulmonary embolism in patients with bleeding risk.
- Treatment of Renally Impaired Patients With Venous Thromboembolism: Awaiting the VERDICTFebruary 13, 2019 | March-April 2019, Volume 16, Issue 2
Dr. Linkins discusses the VERDICT Trial which compares reduced doses of apixaban and rivaroxaban with standard-of-care in adult patients with symptomatic proximal deep vein thrombosis or pulmonary embolism and moderate or severe renal insufficiency.
- Rivaroxaban Clinical Trials in 2018: Successes, Failures, and Lessons LearnedDecember 21, 2018 | January-February 2019, Volume 16, Issue 1
Dr. Linkins discusses the successes, failures, and lessons from rivaroxaban clinical trials that took place in 2018.
- Prevention of Central Venous Catheter-Related Thrombosis: Reality or Still a Dream?October 10, 2018 | November-December 2018, Volume 15, Issue 6
Dr. Linkins discusses low-molecular weight heparin and direct oral anticoagulants for the prevention of central venous catheter-related thrombosis.
- Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and ThrombocytopeniaAugust 15, 2018 | September-October 2018, Volume 15, Issue 5
Dr. Linkins provides guidance on how to manage recurrent thrombosis and bleeding in a cancer patient with severe thrombocytopenia that develops VTE.
- Ground-Breaking Trial Shows Aspirin Is As Effective As Rivaroxaban Following Hip and Knee ArthroplastyJune 19, 2018 | July-August 2018, Volume 15, Issue 4
Dr. Linkins looks at evidence that demonstrates that aspirin is as effective as oral anticoagulant rivaroxaban post hip and knee arthroplasty in a significant subset of patients.